Table 1.

Number of participants with most often occurring serious adverse events during treatment

Trial	Gastrointestinal haemorrhage		Hepatorenal syndrome (with or without hepatic failure)		Septicaemia		Hepatocellular carcinoma
	Prednisolone	Placebo	Prednisolone	Placebo	Prednisolone	Placebo	Prednisolone	Placebo
Helman 1971				3
Porter 1971	4	2
Campra 1973	3	5		4
Blitzer 1977	3	2		2	2 fungal			1
Mendenhall 1977	Not reported
Maddrey 1978	1	1	3	6
Shumaker 1978	3	3				2
Depew 1980	2	1			2	1
Theodossi 1982	11	6			7	6
Bories 1987	3	3		2
Carithers 1989	2	4			1
Mendenhall 1984								2
Ramond 1992	1	2			1	1
De 2014	2	3	3		3	1